Finance

Beta
Lists
SVA:NASDAQ
Sinovac Biotech Ltd
$6.47
0.00%
(0.00) 1D
Feb 22, 5:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
Shares outstanding
59.32M
No. of employees
3K
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
Shares outstanding
59.32M
No. of employees
3K
News stories
From sources across the web
Profile
Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing, that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government. Wikipedia
About Sinovac Biotech Ltd
CEOWeidong Yin
Employees3.04K
Founded2001
Headquarters-
SectorBiotechnology
Websitesinovac.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Revenue
60.67M
60.67M
65.14M
65.14M
Cost of goods sold
20.42M
20.42M
24.40M
24.40M
Cost of revenue
20.42M
20.42M
24.40M
24.40M
Research and development expenses
72.03M
72.03M
63.46M
63.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
103.17M
103.17M
73.61M
73.61M
Operating expense
174.35M
174.35M
134.89M
134.89M
Total operating expenses
194.76M
194.76M
159.30M
159.30M
Operating income
-134.09M
-134.09M
-94.16M
-94.16M
Other non operating income
83.24M
83.24M
80.95M
80.95M
EBT including unusual items
-32.60M
-32.60M
-47.89M
-47.89M
EBT excluding unusual items
-29.91M
-29.91M
-12.91M
-12.91M
Income tax expense
1.72M
1.72M
390.50K
390.50K
Effective tax rate
-5.26%
-5.26%
-0.82%
-0.82%
Other operating expenses
-522.00K
-522.00K
-1.77M
-1.77M
Net income
-3.95M
-3.95M
-10.83M
-10.83M
Net profit margin
-6.51%
-6.51%
-16.63%
-16.63%
Earnings per share
-
-
-
-
Interest and investment income
22.03M
22.03M
6.47M
6.47M
Interest expense
-1.09M
-1.09M
-2.05M
-2.05M
Net interest expenses
20.94M
20.94M
4.42M
4.42M
Depreciation and amortization charges
-
-
-
-
EBITDA
-99.97M
-99.97M
-69.88M
-69.88M
Gain or loss from assets sale
2.69M
2.69M
26.96M
26.96M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer